New hope could be on the horizon for ALS patients in the form of a “breakthrough" drug, researchers say. Neuvivo is seeking ...
Cari Meystrik was diagnosed with ALS, a progressive neurodegenerative disease affecting nerve cells in the brain and spinal ...
ALS, or Lou Gehrig's Disease, and a certain type of dementia, impact thousands of people each year. Although they may seem ...
A team of researchers from Penn State College of Medicine found that misfolded versions of a protein exhibit tissue-specific toxicity linked to cell degeneration that may be linked to the development ...
A Texas Children’s Hospital investigator won a $2.4 million NIH grant for ALS and other neurodegenerative disease research.
The Walk to End ALS starts at 10 a.m. Oct. 12 at Cosmo-Bethel Park and is focused on raising money for researching the ...
It was a very special morning at Riverside Park as the inaugural Walk to Defeat ALS stepped off just after 10:00 a.m.
The annual Walk to Defeat ALS took place Saturday in Concord and raised more than $100,000. The event raises money for ...
LEXINGTON, Mass. 和 AMSTERDAM – 基因疗法公司uniQure N.V. (NASDAQ: QURE)已启动其针对由SOD1突变引起的ALS的实验性治疗AMT-162的I/II期临床试验。EPISOD1试验的第一位患者已接受剂量,该试验正在美国多个中心进行。 这项开放标签试验将评估AMT-162在SOD1-ALS患者中的安全性、耐受性和初步疗效。SOD1-ALS是一种罕见 ...
The 21st annual 100 Innings of Baseball was held at Adams Field in Qunicy this weekend, where ballplayers — some who<a class= ...
The inaugural 2024 CEO Soak Tallahassee is a fundraising initiative aimed at making a significant impact on ALS research and care for ALS patients.